Lonza expands Swiss drug product site, adds 50 jobs

By Flora Southey contact

- Last updated on GMT

Lonza will feed demand for its drug quality testing and formulation capabilities through an expansion at its Drug Product Services site in Basel, Switzerland.

The Stücki Science Park-based facility launched​ in November 2016 and focuses on parenteral dosage form development.

The expansion will add drug product process development functions to the GMP site, and increase its formulation development, drug product analytics and quality control (QC) capabilities.

Spokesperson Dominik Werner told us the decision to expand the site came from an increased market demand.

“The Drug Product Service ​[DPS] offering was immediately successful in the market, filling up our capacities. That’s why we decided to expand our footprint for parenteral dosage form development with a further build-out of its DPS.”

“The expansion after only one year of operations shows the significant customer need and interest leading to different new business opportunities,”​ he said.

The firm said the expansion will add more than 50 roles to the site.

Small & large molecule

Werner added the facility’s services will include options for small and large molecule drugs.

“Services will include options for monoclonal antibodies, other biologics, drug conjugates, peptides and small molecules that require a parenteral dosage form,”​ he said.

The contract manufacturing organisation (CMO) offers services for parenteral dosage forms including products for injection and infusion for intravenous, subcutaneous, and intraocular routes of administration.

Specialised services also include excipient and surfactant characterisation, extractables and leachables assessment, container closure integrity testing and particulate identification, characterisation and quantification.

Related topics: Facilities, Bio Developments

Related news

Related products

show more

Featured eBook: Complex Protein Production

Featured eBook: Complex Protein Production

Catalent Pharma Solutions | 06-Mar-2018 | Technical / White Paper

Download the eBook written by Catalent experts to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture...


Inline diafiltration enables continuous processing

Pall Life Sciences | 13-Feb-2018 | Application Note

The Cadence inline diafiltration (ILDF) device is designed for continuous processing, in-process buffer exchange or contaminant removal in various processes...

Discover Fast and Simple Water Intrusion Testing

Discover Fast and Simple Water Intrusion Testing

Pall Life Sciences | 13-Nov-2017 | Application Note

At Pall we have supported the water intrusion test for more than 20 years and we developed the Palltronic® AquaWIT IV system to deliver fast and simple...

Think all buffer filters are the same?

Think all buffer filters are the same?

Pall Life Sciences | 01-Nov-2017 | Application Note

Pall’s Supor ® buffer filters are designed for high flow rates and rapid microbial removal. This can mean dramatic reductions in buffer handling costs...

Related suppliers